Bharat Biotech's Covaxin out of clinical trial mode, granted restricted emergency use authorisation - Job Community
Responsive Ads Here

Post Top Ad

Your Ad Spot

Thursday, 11 March 2021

Bharat Biotech's Covaxin out of clinical trial mode, granted restricted emergency use authorisation

NITI Aayog member (Health) Dr V K Paul confirmed that both Covid-19 vaccines - Covishield manufactured by Serum Institute and Bharat Biotech's Covaxin have the same licensure status now.



from Jagran Josh https://ift.tt/3cuH3ku

No comments:

Post a Comment

Post Top Ad

Your Ad Spot